请使用支持JavaScript的浏览器!
聚乙二醇(PEG)衍生物、PEG共聚合物、单分散PEG、定制PEG衍生物合成和聚乙二醇化服务
℡ 4000-520-616
℡ 4000-520-616
JENKEM/Y-shape PEG NHS Ester/A0001-1\/Y-NHS-40K
产品编号:Y-NHS-40K
市  场 价:¥2600.00
场      地:美国(厂家直采)
产品分类: 生化试剂>其他>>
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$130.00
品      牌: JenKem
公      司:JenKem Technology USA
公司分类:
JENKEM/Y-shape PEG NHS Ester/A0001-1\/Y-NHS-40K
商品介绍

Description

Y-shapePEGNHSEster withsuperiorqualityspecificationof ≥95%Substitution.

Y-shapePEGNHS fromJenKemTechnologyisaSuccinimidylCarboxymethylEsterbranched2ARMPEG,reactivetowardstheaminogroupoflysine(s)onproteinsorotherBIOLOGics.AminePEGylationwithY-shapePEGNHScanbecompletedinlessthan1hratpH7-8.JenKemproprietaryY-shapePEGsaremoreselective,duetotheirstericallybulkystructure.PleasereviewtheapplicationnoteforthisproductforadditionalinstructionsforaminePEGylationwithY-NHS-40K.

Scheme of Protein PEGylation with JenKem® Y-PEG-NHS

SchematicofProteinPEGylationwithJenKem®Y-PEG-NHS

JenKemTechnologyoffers Y-shapePEGNHS withMW40000,in1gand10gpackingsizes. JenKemTechnology providesrepackagingservicesforanadditionalfee,pleasecontactusifyourequireadifferentpackagesizethanourcatalogselection.

DifferentMWof Y-shapePEGNHS productsmaybeavailablebycustomsynthesis,pleaseemailus attech@jenkemusa.comfordetailsoncustomPEGs.

BulkPEGsandGMPgradePEGsaremade-to-order.Please contactus forbulkpricing.

ApplicationofY-NHS-40KforPEGylation:

DrugMoleculeorOtherEntityPEGylatedwithY-NHS-40KReferences
Calciumphosphatenanoparticles7
Cp404
DNAaptamer(SOMAmer)2
G-CSF15
Gentamicin14
IFN-α2a16
IFN-α2b17
LIFreceptorantagoNIST(LA)11
L-RNA(Spiegelmer)5
L-RNA(Spiegelmer)8
rhGH18
TNF-α9,10

ClickheretodownloadtheMSDS

References:

1.AlQahtani,A.D.,etal.,Productionof“biobetter”glucarpidasevariantstoimprovedrugdetoxificationandantibodydirectedenzymeprodrugtherapyforcancertreatment,EuropeanJournalofPharmaceuticalSciences,2019,127,P.79-91.

2.Haruta,K.,etal.,ANovelPEGylationMethodforImprovingthePharmacokineticPropertiesofAnti-Interleukin-17ARNAAptamers,Nucleicacidtherapeutics,2017,27(1):36-44.

3.Guo,L.,etal.,ApplicationInstructionsforY-NHS-40KforAminePEGylation,click link.

4.Masao,H.,etal.,ChemicallyModifiedInterleukin-6AptamerInhibitsDevelopmentofCollagen-InducedArthritisinCynomolgusMonkeys,NucleicAcidTherapeutics,2015.

5. Winship,A.L.,Interleukin-11altersplacentationandcausespreeclampsiafeaturesinmice,ProcNatlAcadSciUSA.,2015,112(52):15928-33.

6. Risitano,A.M.,etal., PeptideinhibitorsofC3activationasanovelstrategyofcomplementinhibitionforthetreatmentofparoxysmalnocturnalhemoglobinuria, BloodMar,2014,123(13)2094-2101.

7.Roccaro,Aldo M.etal., SDF-1InhibitionTargetstheBoneMarrowNicheforCancerTherapy, CellReports,2014,9(1),p:118–128.

8. Stefan,N.,etal.,NovelProdrug-LikeFusionToxinwithProtease-SensitiveBioorthogonalPEGylationforTumorTargeting,Bioconjugatechemistry, 2014,25.12:2144-2156.

9.Ashokan,A.,etal.,Multifunctionalcalciumphosphatenano-contrastagentforcombinednuclear,magneticandnear-infraredin vivoimaging.Biomaterials,2013,34(29):p.7143-7157.

10.Khan,M.A.,etal., Targetingcomplementcomponent5apromotesvascularintegrityandlimitsairwayremodeling,PNAS,2013,110(15)p:6061-6066.

11. Dai,C.Y., etal.,PreparationandevaluationofanewreleasablePEGylatedtumornecrosisfactor-α(TNF-α)conjugatefortherapeuticapplication,ScienceChinaLifeSciences,2013,56.1:51-58.

12.Dai, C.Y.,etal., LinkagewithcathepsinB-sensitivedipeptidepromotestheinvitroandinvivoanticanceractivityofPEGylatedtumornecrosisfactor-alpha(TNF-α)againstmurinefibrosarcoma, ScienceChinaLifeSci,2011,54(2):128–138.

13. Menkhorst,E.,etal.,VaginallyAdministeredPEGylatedLIFAntagonistBlockedEmbryoImplantationandEliminatedNonTargetEffectsonBoneinMice,PLoSONE, 2011,6(5)e19665.

14. Cai,Y.,etal.,Separationofexenatideanaloguemono-PEGylatedwith40kDApolyethyleneglycolbycationexchangechromatography,JournalofChromatographyA,2011,1218:39,P.6953-6960.

15. Wang,Y-J.,etal.,PEGylationmarkedlyenhancestheinvivopotencyofrecombinanthumannon-glycosylatederythropoietin:Acomparisonwithglycosylatederythropoietin,JournalofControlledRelease, 2010,145:3,p. 306-313.

16.Marcus,Y.,etal.,TurningLow-Molecular-WeightDrugsintoProlongedActingProdrugsbyReversIBLePegylation:AStudywithGentamicin, JournalofMedicinalChemistry,2008,51(14),4300-4305.

17.Wang,S.,etal.,Y-typepolyethyleneglycolmodifiedG-CSFandpreparationmethodandusethereof.PatentCN200780051378,2007.

18.Zhou,W.,etal.,Interferonalpha2amodifiedbypolyethyleneglycol,itssynthesisprocessandapplication.PatentCN200780050541,2007.

19.Zhou,W.,etal.,Interferonalpha2bmodifiedbypolyethyleneglycol,itssynthesisprocessandapplication.PatentCN200780050542,2007.

20.Zhou,W.,etal.,Double-strandedpolyethyleneglycolmodifiedgrowthhormone,preparationmethodandapplicationthereof.PatentCN200880009718,2008.

Foundedin2001byexpertsinPEGsynthesisandPEGylation,JenKemTechnologyspecializesexclusivelyinthedevelopmentandmanufacturingofhighqualitypolyethyleneglycol(PEG)productsandderivatives,andrelatedcustomsynthesisandPEGylationservices.JenKemTechnologyisISO9001andISO13485certified,andadherestoICHQ7AguidelinesforGMPmanufacture.TheproductionofJenKem®PEGsisback-integratedtoin-housepolymerizationfromethyleneoxide,enablingfaciletraceABIlityforregulatedcustomers.JenKemTechnologycaterstothePEGylationneedsofthepharmaceutical,biotechnology,medicaldeviceanddiagnostics,andemergingchemicalspecialtymarkets,fromlaboratoryscalethroughlargecommercialscale.

品牌介绍

JenKem Technology由PEG合成和PEG化的专家成立于2001年,专门从事高纯度,低多分散性的聚乙二醇(PEG)衍生物,PEG共聚物,单分散PEG,定制PEG衍生物合成和PEG化服务。通过获得本体环氧乙烷以及内部所有聚合和衍生化的性能来支持特定的强度。

JenKem Technology从研发到GMP商业批量提供全球PEG衍生物,用于临床前,临床试验以及用于制药,生物技术,医疗设备和诊断的商业产品。


自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔